ER
Elena Riva
IRCCS Humanitas Research Hospital, King's College London, University of Milano-Bicocca, Vita-Salute San Raffaele University
Research areas: Medicine · Hematology · Acute Myeloid Leukemia Research · Retinoids in leukemia and cellular processes · Hematopoietic Stem Cell Transplantation
Employment
-
IRCCS Humanitas Research Hospital Postdoctoral Fellow2024 - Present
-
King's College London Visiting PhD student2023 - 2023
-
IRCCS Humanitas Research Hospital PhD Student2021 - 2024
-
Vita-Salute San Raffaele University Research Fellowship2019 - 2020
-
Vita-Salute San Raffaele University Thesis internship2018 - 2019
Education
-
University of Milano-Bicocca PhD in Translational and Molecular Medicine2021 - 2024
-
Vita-Salute San Raffaele University Master's degree in Medical, Molecular and Cellular Biotechnologies2017 - 2019
-
University of Milano-Bicocca Bachelor's degree in Biological sciences2014 - 2017
Projects & Funding
Projects & funding information is unavailable.
Publications (13)
- Real‐world, multi‐omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS) Save
- PU.1-activated genomic regions define low-risk MDS subsets characterized by immune dysregulation and disease progression Save
- Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia. Save
- Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic Syndromes Save
- Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes Save
- Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium Save
- Mutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DRlow/neg monocytes in lower-risk myelodysplastic neoplasms Save
- A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study Save
- Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes Save
- Synthetic Data Generation by Artificial Intelligence to Accelerate Research and Precision Medicine in Hematology Save
- Clinical relevance of clonal hematopoiesis in persons aged ≥80 years Save
- The genetics of myelodysplastic syndromes: Clinical relevance Save
- The Interaction of the Tumor Suppressor FAM46C with p62 and FNDC3 Proteins Integrates Protein and Secretory Homeostasis Save